v3.26.1
SCHEDULE OF OPTION ACTIVITY FOR BEYOND CANCER (Details) - 2021 Beyond Cancer Ltd Equity Incentive Plan [Member] - USD ($)
3 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding at beginning of period 2,254,500  
Weighted Average Exercise Price - Options, Outstanding at beginning of period $ 5.50  
Weighted average remaining contractual life - options, outstanding at beginning of period 5 years 10 months 24 days 6 years 2 months 12 days
Aggregate Intrinsic Value, Outstanding at beginning of period  
Number of Options, Granted  
Weighted Average Exercise Price of Options, Granted  
Number of Options, Exercised  
Weighted Average Exercise Price of Options, Exercised  
Number of Options, Forfeited (25,750)  
Weighted Average Exercise Price of Options, Forfeited $ 5.50  
Number of Options, Outstanding at ending of period 2,228,750 2,254,500
Weighted Average Exercise Price - Options, Outstanding at ending of period $ 5.50 $ 5.50
Aggregate Intrinsic Value, Outstanding at end of period
Number of Options Outstanding, Exercisable 2,087,500  
Weighted Average Exercise Price - Options, Exercisable $ 5.50  
Weighted Average Remaining Contractual Life of Options, Exercisable 5 years 10 months 24 days  
Aggregate Intrinsic Value, Exercisable